Global Life science leader keenly focused on capturing opportunities and managing impacts created by the digitization in a quest to save patient's lives.
As Global Cell and Gene Lead, I am focused on helping clients build necessary digital ecosystem to support blockbuster individualized therapies (immunotherapy and regenerative therapies) to tackle rare diseases.
Highly analytical leader with diverse experience in streamlining both operational processes and product implementations in both the Pharmaceutical and Financial Services verticals. Ability to manage large global teams of varied capacity ranging from experts in IT, Science, Marketing and Legal.
Adept at working with C-Suite Executives to determine business needs and develop innovative strategies to address these needs. Aiding them in increasing operational efficiency, reducing costs, developing go-to-market strategies, assisting in drug commercialization and significantly improving their time to market.
Ability to recognize areas of redundancy and inefficiency in order to cut process speeds in half by reducing the need for manual activities as well as simultaneously reducing errors inherent in manual processes.
I have also worked with Private Equity and Holding companies raising capital for life science firms.
&nsbp;
